Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GTX Inc (NASDAQ:GTXI)

0.76
Delayed Data
As of 3:27pm ET
 +0.016 / +2.15%
Today’s Change
0.29
Today|||52-Week Range
1.17
+8.57%
Year-to-Date
No recent news for GTX Inc.

Today’s Trading

Previous close0.74
Today’s open0.74
Day’s range0.73 - 0.77
Volume108,064
Average volume (3 months)204,459
Market cap$105.6M
Dividend yield--
Data as of 3:27pm ET, 09/29/2016

Growth & Valuation

Earnings growth (last year)+68.75%
Earnings growth (this year)+20.00%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)--
P/E ratio4.2
Price/Sales--
Price/Book56.19

Competitors

 Today’s
change
Today’s
% change
PPHMPeregrine Pharmaceut...-0.01-1.44%
REPHRecro Pharma Inc-0.18-1.99%
SBBPStrongbridge Biophar...+0.22+4.37%
CTICCTi Biopharma Corp-0.00-0.11%
Data as of 3:43pm ET, 09/29/2016

Financials

Next reporting dateNovember 8, 2016
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$18.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Class I Director
Marc Steven Hanover
Principal Financial &
Accounting Officer
Jason T. Shackelford
Corporate headquarters
Memphis, Tennessee

Forecasts

Search for Jobs